MedInvest, a leading healthcare, biotech, and medtech media and conference company, will host its semi-annual Biotech and Pharma Investor Conference in Palo Alto, CA on September 24 and 25, 2025.  The National Institutes of Health and Cooley Law Firm will be presenting partners of the event.

 

The conference is expected to attract 100+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.

 

During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.

​

Speakers include:

Dr. Ira Mellman, President of Research, Parker Center for Cancer Immunotherapy | Former Vice President of Cancer Immunology, Genetech

Dr. Dean Felsher, Director of Translational Research and Applied Medicine, Stanford Medical School | Professor Medicine-Oncology and Pathology

Dr. Chris Apfel, Director of Life Sciences, Keiretsu Forum Bay Area | Founder and CEO, SageMedic

Dr. Phil DiGiacomo, Vice President, Venrock

Lior Teitelbaum, Principal, Venture Investments with J&J (JJDC)

Dr. Preetha Ram, Managing Partner, Pier 70 Ventures

Dr. Michel Azoulay, Chief Medical Officer, Institute for Follicular Lymphoma Innovation  Institute for Follicular Lymphoma Innovation

Dr. Edny Inui, Partner, Palo Santo

Dr. Qing Zhang, Partner, LDV Partners

Dr. Chris Walters, Director of Investments and Business Development, Formation Bio

Dr. Abe Heifets, Founder, Atomwise

Dr. Hanadie Yousef, CEO, Juvena Therapeutics 

Dr. Alfred Slanetz, Chairman of the National Foundation for Cancer Research and Former CEO iof Bluebird Bio

Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, NIH

Dr. Michael Salgaller, Director of the Invention Development and Marketing Unit, NCI

Josh Seidenfeld, Partner, Cooley

Lauren Creel, Partner, Cooley

Lila Hope, Partner, Cooley

​

REGISTER HERE